Thomas Perone
Compliance Officer at OVID THERAPEUTICS INC.
Net worth: 39 603 $ as of 2024-05-30
Thomas Perone active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OVID THERAPEUTICS INC. | Compliance Officer | - | - |
| General Counsel | 2019-03-20 | - | |
| Corporate Secretary | 2019-03-20 | - |
Career history of Thomas Perone
Former positions of Thomas Perone
| Companies | Position | Start | End |
|---|---|---|---|
| CELGENE | General Counsel | 2006-03-31 | - |
| Corporate Secretary | 2014-05-31 | 2018-04-30 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | General Counsel | 2001-11-30 | 2006-03-31 |
| Proskauer Rose LLC | Corporate Officer/Principal | - | - |
Training of Thomas Perone
| Rutgers State University of New Jersey | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| Seton Hall University School of Law | Graduate Degree |
Statistics
International
| United States | 7 |
| France | 2 |
Operational
| General Counsel | 3 |
| Corporate Secretary | 2 |
| Compliance Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
| Proskauer Rose LLC |
- Stock Market
- Insiders
- Thomas Perone
- Experience
